News
Key Points Pfizer’s earnings and stock price soared in early pandemic days thanks to its coronavirus treatment and ...
A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...
It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...
Shares are down in the year to date and 20% off their 52-week high, but analysts see 30% upside ahead for Pfizer.
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...
Explore more
You can buy shares of Healthpeak Properties and Pfizer with well less than $100 at the moment. At the moment, anyone with ...
The Private Placement included participation by prominent crypto venture capital firms and blockchain infrastructure providers including FalconX, Pantera, Borderless and Relayer Capital with strong ...
Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...
Pfizer recently recalibrated its evaluation score, a nod to shifting trends in the market and its own financial pulse. The ...
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results